Risk Identification of the GlucoTab System in Routine Use

Medical University of Graz

Status: Completed

Conditions: Diabetes Mellitus

Study type: Observational

Funder types: Other

Identifiers

NCT02053077

ClinDiab-05

Details and patient eligibility

About

Identification of risks of the GlucoTab system in routine use.

Full description

A study to identify risks in routine use of the GlucoTab system for glycaemic management in non-critically ill patients with type 2 diabetes at general wards.

Enrollment: 150 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• informed consent obtained after being advised of the nature of the study
• type 2 diabetes or new-onset hyperglycaemia which require s.c. insulin therapy during hospital stay
• diabetes therapy supported by GlucoTab system

Exclusion criteria

• type 1 diabetes mellitus
• intravenous insulin therapy
• hyperglycaemic episodes (ketoacidosis, hyperosmolar state) if they require intravenous insulin therapy
• gestational diabetes or pregnancy
• known or suspected allergy to certain insulin types, named in the user manual
• total parenteral nutrition (TPN)
• any mental condition rendering the patient incapable of giving his consent